Five Prime Therapeutics, Inc. (NASDAQ: FPRX) kicked off the Tuesday session with a strong performance. Shares of Five Prime surged 366.29% in the pre-market hours of Wednesday after it disclosed the positive result from the Phase II FIGHT trial. The Phase II Fight